Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
about
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillinPharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication.Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system
P2860
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
@ast
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
@en
type
label
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
@ast
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
@en
prefLabel
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
@ast
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
@en
P2093
P2860
P1476
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
@en
P2093
C C Sanders
P D Lister
W E Sanders
P2860
P304
P407
P577
1998-07-01T00:00:00Z